Dyne Therapeutics (DYN) PT Lowered to $12 at Piper Sandler
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $7.20 +4.80%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 10
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 10
Join SI Premium – FREE
Piper Sandler lowered its price target on Dyne Therapeutics (NASDAQ: DYN) to $12.00 (from $16.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Coupang (CPNG) Market Share to Reach 26% in 2023, Says Analyst
- Medmix AG (MEDX:SW) PT Lowered to CHF37 at UBS
- JPMorgan Downgrades Oil & Natural Gas Corp Ltd. (ONGC:IN) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
